News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,770 Results
Type
Article (40204)
Company Profile (76)
Press Release (513490)
Multimedia
Podcasts (50)
Webinars (13)
Section
Business (152615)
Career Advice (2455)
Deals (27953)
Drug Delivery (99)
Drug Development (72959)
Employer Resources (142)
FDA (13696)
Job Trends (12242)
News (272476)
Policy (27181)
Tag
Academia (2543)
Academic (1)
Accelerated approval (7)
Adcomms (27)
Allergies (89)
Alliances (38603)
ALS (110)
Alzheimer's disease (1461)
Antibody-drug conjugate (ADC) (155)
Approvals (13683)
Artificial intelligence (285)
Autoimmune disease (30)
Automation (17)
Bankruptcy (312)
Best Places to Work (9969)
BIOSECURE Act (15)
Biosimilars (103)
Biotechnology (62)
Bladder cancer (92)
Brain cancer (34)
Breast cancer (346)
Cancer (2740)
Cardiovascular disease (220)
Career advice (2066)
Career pathing (33)
CAR-T (177)
CDC (28)
Cell therapy (468)
Cervical cancer (19)
Clinical research (60310)
Collaboration (865)
Company closure (3)
Compensation (354)
Complete response letters (24)
COVID-19 (2498)
CRISPR (54)
C-suite (337)
Cystic fibrosis (94)
Data (2900)
Decentralized trials (2)
Denatured (7)
Depression (70)
Diabetes (329)
Diagnostics (5809)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (39)
Drug discovery (125)
Drug pricing (116)
Drug shortages (26)
Duchenne muscular dystrophy (118)
Earnings (56137)
Editorial (42)
Employer branding (19)
Employer resources (131)
Events (77625)
Executive appointments (852)
FDA (15208)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (122)
Generative AI (23)
Gene therapy (373)
GLP-1 (763)
Government (4216)
Grass and pollen (5)
Guidances (178)
Healthcare (16129)
Huntington's disease (30)
IgA nephropathy (42)
Immunology and inflammation (164)
Immuno-oncology (7)
Indications (36)
Infectious disease (2669)
Inflammatory bowel disease (138)
Inflation Reduction Act (10)
Influenza (61)
Intellectual property (110)
Interviews (528)
IPO (12761)
IRA (46)
Job creations (2607)
Job search strategy (1685)
Kidney cancer (15)
Labor market (31)
Layoffs (444)
Leadership (26)
Legal (5809)
Liver cancer (75)
Lung cancer (405)
Lymphoma (201)
Machine learning (10)
Management (51)
Manufacturing (322)
MASH (98)
Medical device (10769)
Medtech (10773)
Mergers & acquisitions (15827)
Metabolic disorders (821)
Multiple sclerosis (94)
NASH (23)
Neurodegenerative disease (119)
Neuropsychiatric disorders (38)
Neuroscience (2136)
NextGen: Class of 2025 (5527)
Non-profit (3999)
Now hiring (38)
Obesity (406)
Opinion (232)
Ovarian cancer (96)
Pain (102)
Pancreatic cancer (115)
Parkinson's disease (177)
Partnered (18)
Patents (281)
Patient recruitment (157)
Peanut (44)
People (51125)
Pharmaceutical (22)
Pharmacy benefit managers (14)
Phase I (18563)
Phase II (26516)
Phase III (20242)
Pipeline (1564)
Policy (187)
Postmarket research (2314)
Preclinical (7622)
Press Release (61)
Prostate cancer (132)
Psychedelics (43)
Radiopharmaceuticals (223)
Rare diseases (445)
Real estate (4129)
Recruiting (57)
Regulatory (19504)
Reports (29)
Research institute (2124)
Resumes & cover letters (359)
Rett syndrome (10)
RNA editing (7)
RSV (45)
Schizophrenia (92)
Series A (140)
Series B (94)
Service/supplier (3)
Sickle cell disease (59)
Special edition (13)
Spinal muscular atrophy (146)
Sponsored (31)
Startups (2757)
State (2)
Stomach cancer (15)
Supply chain (63)
Tariffs (49)
The Weekly (42)
Vaccines (725)
Venture capital (43)
Weight loss (255)
Women's health (36)
Worklife (17)
Date
Today (61)
Last 7 days (332)
Last 30 days (1670)
Last 365 days (27502)
2025 (14747)
2024 (30703)
2023 (34520)
2022 (45064)
2021 (48409)
2020 (46745)
2019 (39825)
2018 (30160)
2017 (27061)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (727)
Alabama (57)
Alaska (5)
Arizona (153)
Arkansas (11)
Asia (34453)
Australia (7097)
California (6278)
Canada (2118)
China (612)
Colorado (271)
Connecticut (246)
Delaware (174)
Europe (76272)
Florida (1007)
Georgia (205)
Idaho (51)
Illinois (546)
India (23)
Indiana (310)
Iowa (13)
Japan (210)
Kansas (92)
Kentucky (23)
Louisiana (13)
Maine (52)
Maryland (904)
Massachusetts (4384)
Michigan (219)
Minnesota (345)
Mississippi (2)
Missouri (81)
Montana (20)
Nebraska (22)
Nevada (72)
New Hampshire (65)
New Jersey (1846)
New Mexico (20)
New York (1781)
North Carolina (886)
North Dakota (6)
Northern California (2739)
Ohio (190)
Oklahoma (7)
Oregon (25)
Pennsylvania (1336)
Puerto Rico (17)
Rhode Island (29)
South America (996)
South Carolina (30)
South Dakota (1)
Southern California (2418)
Tennessee (102)
Texas (981)
United States (23112)
Utah (204)
Virginia (163)
Washington D.C. (59)
Washington State (533)
West Virginia (4)
Wisconsin (49)
553,770 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CDC
CDC Scientist Resigns in Protest as Kennedy Reshapes Vaccine Regulation
HHS Secretary Robert F. Kennedy Jr.’s actions in recent months have raised concerns that he is taking a heavy-handed and unilateral approach to vaccine policy in the U.S.
June 17, 2025
·
2 min read
·
Tristan Manalac
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Press Releases
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
·
5 min read
Press Releases
PNRI Podcast Explores How Rare Disease Research Is Reshaping Medicine for All
May 28, 2025
·
2 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
May 23, 2025
·
3 min read
Press Releases
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
May 1, 2025
·
6 min read
Press Releases
ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting
January 27, 2025
·
9 min read
Press Releases
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry
July 3, 2025
·
3 min read
1 of 55,377
Next
